
- Oncology
- Exited
Maverick Therapeutics is a preclinical stage biotech company founded by MPM that is developing a novel class of T cell- redirecting antibody. Critical to the opportunity, the antibodies are designed to expand the therapeutic index via their conditional activation in the tumor microenvironment.
mavericktx.com